According to Yunnan Baiyao, on October 29, 2026, the flurbiprofen gel patch developed by the Wuxi Center of the Central Research Institute of Yunnan Baiyao Group and declared by Yunnan Baiyao Group Wuxi Pharmaceutical Co., Ltd. was accepted by the China Drug Administration for drug registration and marketing. As a non-steroidal anti-inflammatory drug, flubiprofen gel patch is clinically used for anti-inflammatory analgesia such as osteoarthritis, periodontal inflammation, muscle pain, and traumatic swelling and pain.

According to Yunnan Baiyao, on October 29, 2026, the flurbiprofen gel patch developed by the Wuxi Center of the Central Research Institute of Yunnan Baiyao Group and declared by Yunnan Baiyao Group Wuxi Pharmaceutical Co., Ltd. was accepted by the China Drug Administration for drug registration and marketing. As a non-steroidal anti-inflammatory drug, flubiprofen gel patch is clinically used for anti-inflammatory analgesia such as osteoarthritis, periodontal inflammation, muscle pain, and traumatic swelling and pain.